Microscale culture of human liver cells for drug development
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Tissue function depends on hierarchical structures extending from single cells ( approximately 10 microm) to functional subunits (100 microm-1 mm) that coordinate organ functions. Conventional cell culture disperses tissues into single cells while neglecting higher-order processes. The application of semiconductor-driven microtechnology in the biomedical arena now allows fabrication of microscale tissue subunits that may be functionally improved and have the advantages of miniaturization. Here we present a miniaturized, multiwell culture system for human liver cells with optimized microscale architecture that maintains phenotypic functions for several weeks. The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicity. We demonstrate utility through assessment of gene expression profiles, phase I/II metabolism, canalicular transport, secretion of liver-specific products and susceptibility to hepatotoxins. The combination of microtechnology and tissue engineering may enable development of integrated tissue models in the so-called 'human on a chip'.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, hepatic models that utilize conventional 2D mono-and co-cultures of normal and diseased human cells fail to mimic the complex threedimensional (3D) in vivo microenvironment and extracellular matrix (ECM) support [16,19,20].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [16]
In the citing paper
“The oxygenated or microfabricated co-cultures have been reported to allow HHs to retain metabolic function for a few weeks; however, these cells lose their proliferative capacity (Khetani and Bhatia, 2008; Kidambi et al., 2009”
From In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity (2018) · cites this paper as Khetani and Bhatia, 2008
Citations
Cites
Geometric Control of Cell Life and Death
Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M., & Ingber, D. E. (1997) · Science · doi:10.1126/science.276.5317.1425 · Cited by 4,657 · cited 1×
“Over the last decade, microtechnology tools have emerged to probe biomedical phenomena at relevant length scales and to miniaturize and parallelize biomedical assay”
BackgroundRheinwatd, J. G., & Green, H. (1975) · Cell · doi:10.1016/s0092-8674(75)80001-8 · Cited by 4,537
Soft Lithography in Biology and Biochemistry
Whitesides, G. M., Ostuni, E., Takayama, S., Jiang, X., & Ingber, D. E. (2001) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.3.1.335 · Cited by 2,607 · cited 1×
“Our approach incorporates 'soft lithography' techniques, using reusable, elastomeric molds of microfabricated structures to overcome limitations of photolithograph”
MethodIdiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054 · cited 1×
“The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicit”
BackgroundGenome-wide expression monitoring in Saccharomyces cerevisiae
Wodicka, L., Dong, H., Mittmann, M., Ho, M.-H., & Lockhart, D. J. (1997) · Nature Biotechnology · doi:10.1038/nbt1297-1359 · Cited by 973
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890
Self-citationWilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 1×
“Although hepatocarcinoma-derived cell lines and immortalized hepatocytes can be reproducible and inexpensive, they display abnormal levels of liver-specific function”
BackgroundHewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Newton, D. J., Wang, R. W., & Lu, A. Y. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06500-6 · Cited by 605
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Cited by
Items 401–500 of 1,000
Advances in microfluidics for drug discovery
Lombardi, D., & Dittrich, P. S. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.521149 · Cited by 56
“Up to now, based on microfluidic technology, several models have been fabricated: blood vessels [146,147], muscles [148], bones [149], airways [150], liver [151-154], brain [155], gut [156] and kidney [157,158].”
BackgroundRamsden, D., Zhou, J., & Tweedie, D. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065326 · Cited by 56
“HepatoPac plates were prepared by the manufacturer as previously described (Khetani and Bhatia, 2008) prior to shipment to Boehringer Ingelheim Pharmaceuticals (BIPI, Ridgefield, CT).”
Evolution of Experimental Models of the Liver to Predict Human Drug Hepatotoxicity and Efficacy
Vernetti, L. A., Vogt, A., Gough, A., & Taylor, D. L. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.013 · Cited by 58
Nazari, M., Rashidi, S., & Esfahani, J. A. (2019) · International Communications in Heat and Mass Transfer · doi:10.1016/j.icheatmasstransfer.2019.104293 · Cited by 56
Capillary Based Patterning of Cellular Communities in Laterally Open Channels
Lee, S. H., Heinz, A. J., Shin, S., Jung, Y., Choi, S., Park, W., Roe, J., & Kwon, S. (2010) · Analytical Chemistry · doi:10.1021/ac902903q · Cited by 56
State-of-the-art liver disease research using liver-on-a-chip
Deguchi, S., & Takayama, K. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00248-0 · Cited by 46
Biomaterials-based microfluidics for engineered tissue constructs
Bettinger, C. J., & Borenstein, J. T. (2010) · Soft Matter · doi:10.1039/c0sm00247j · Cited by 55
Trask, O. J., Moore, A., & LeCluyse, E. L. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2013.525 · Cited by 53
“9 This approach utilizes microtechnologies adapted from the semiconductor industry to both optimize and miniaturize an in vitro model of the liver in a multiwell format.”
Haque, A., Gheibi, P., Gao, Y., Foster, E., Son, K. J., You, J., Stybayeva, G., Patel, D., & Revzin, A. (2016) · Scientific Reports · doi:10.1038/srep33980 · Cited by 54
Young, T., Tu, H.-R., Chan, C., Huang, Y., Yen, M.-H., Cheng, N., Chiu, H., & Lin, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.05.065 · Cited by 55
Electrical impedimetric biosensors for liver function detection
Chuang, Y.-H., Chang, Y.-T., Liu, K.-L., Chang, H., & Yew, T. (2011) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2011.07.049 · Cited by 55
A critical assessment of in vitro tissue models for ADME and drug delivery
Vellonen, K., Malinen, M. M., Mannermaa, E., Subrizi, A., Toropainen, E., Lou, Y., Kidron, H., Yliperttula, M. L., & Urtti, A. O. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.044 · Cited by 56
“Micropatterned hepatocyte co-cultures with fibroblasts have maintained the liver-specific functions, including phase I and phase II drug metabolism and active transport for several weeks [235,236].”
BackgroundAutomation of Three-Dimensional Cell Culture in Arrayed Microfluidic Devices
Montanez-Sauri, S. I., Sung, K. E., Puccinelli, J. P., Pehlke, C., & Beebe, D. J. (2011) · JALA: Journal of the Association for Laboratory Automation · doi:10.1016/j.jala.2011.02.003 · Cited by 49
Quantifying co-cultured cell phenotypes in high-throughput using pixel-based classification
Logan, D. J., Shan, J., Bhatia, S. N., & Carpenter, A. E. (2015) · Methods · doi:10.1016/j.ymeth.2015.12.002 · Cited by 54
“Co-culture systems are also being used to study cellular biomechanics in cell migration [1], hepatocyte functions (transporters, metabolism, regeneration, infection, toxicity, extracellular matrix, and tissue structure/function relationships, development, and size control) [2], embryogenesis (growth, development, auto…”
BackgroundSelf-citationIdiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays
Roth, A. D., & Lee, M. (2017) · BioMed Research International · doi:10.1155/2017/9176937 · Cited by 54
Bone and Joint‐on‐Chip Platforms: Construction Strategies and Applications
Du, C., Liu, J., Liu, S., Xiao, P., Chen, Z., Chen, H., Huang, W., & Lei, Y. (2024) · Small Methods · doi:10.1002/smtd.202400436 · Cited by 53
Kim, Y.-H., Larkin, A. L., Davis, R. M., & Rajagopalan, P. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0695 · Cited by 53
“35,36 The presence of canaliculi was determined through the localization of a fluorescent di-peptyl peptidase IV enzyme.”
Pulsipher, A., Dutta, D., Luo, W. F., & Yousaf, M. N. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201404099 · Cited by 53
Integrated microfluidic system for cell co-culture and simulation of drug metabolism
Jie, M., Li, H.-F., Lin, L., Zhang, J., & Lin, J.-M. (2016) · RSC Advances · doi:10.1039/c6ra10407j · Cited by 54
Engineered Livers for Infectious Diseases
Gural, N., Mancio-Silva, L., He, J., & Bhatia, S. N. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.11.005 · Cited by 47
Self-citationLiu, W., Li, L., Wang, J., Tu, Q., Ren, L. M., Wang, Y., & Wang, J. (2012) · Lab on a Chip · doi:10.1039/c2lc00034b · Cited by 53
Hepatocyte spheroid arrays inside microwells connected with microchannels
Fukuda, J., & Nakazawa, K. (2011) · Biomicrofluidics · doi:10.1063/1.3576905 · Cited by 51
An evaluation of the latestin vitrotools for drug metabolism studies
Costa, A., Sarmento, B. F. C. C., & Seabra, V. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.857402 · Cited by 52
“A relationship between the manteinance of 3D cell architecture and its differentiate state was founded, providing the hepatocytes survival, phenotype preservation and improvement of some specific liver functions, such as albumin secretion and CYP activity induction [49-56].”
BackgroundYang, Y., Li, J., Pan, X., Zhou, P., Yu, X., Cao, H., Wang, Y., & Li, L. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24752 · Cited by 44
Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture model
Nelson, L. J., Navarro, M., Treskes, P., Samuel, K., Tura-Ceide, O., Morley, S. D., Hayes, P. C., & Plevris, J. N. (2015) · Scientific Reports · doi:10.1038/srep17455 · Cited by 53
Devarasetty, M., Forsythe, S., Shupe, T., Soker, S., Bishop, C., Atala, A., & Skardal, A. (2017) · Biosensors · doi:10.3390/bios7030024 · Cited by 49
“A wide variety of commercially available assays may be employed to measure cell death and decreases in cell function [12].”
BackgroundLiver microphysiological platforms for drug metabolism applications
Kulsharova, G., & Kurmangaliyeva, A. (2021) · Cell Proliferation · doi:10.1111/cpr.13099 · Cited by 52
Açıkgöz, A., Giri, S., Cho, M.-G., & Bader, A. (2013) · Biomolecules · doi:10.3390/biom3010242 · Cited by 51
“There is an urgent need for a three-dimensional culture system to facilitate either shorter or longer term cultures of hepatocytes for diagnostics, therapeutic applications, drug evaluation, and basic and clinical screening processes [50].”
BackgroundModularly assembled porous cell-laden hydrogels
Liu, B., Liu, Y., Lewis, A. K., & Shen, W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.069 · Cited by 51
Dixit, V. S., Moore, A., Tsao, H., & Hariparsad, N. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067173 · Cited by 51
“The HepatoPac coculturemodel consists of primary hepatocytes that are micropatterned to form a discrete microarchitecture or “hepatocyte islands” that are surrounded by supporting fibroblasts resulting in longterm viability and metabolic function for several weeks (Khetani and Bhatia, 2008).”
BackgroundMethodInfluentialShen, J. X., Youhanna, S., Zandi Shafagh, R., Kele, J., & Lauschke, V. M. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00245 · Cited by 49
Targeting liver stage malaria with metformin
Vera, I., Ruivo, M. T. G., Rocha, L. F. L., Marques, S., Bhatia, S. N., Mota, M. M., & Mâncio-Silva, L. (2019) · JCI Insight · doi:10.1172/jci.insight.127441 · Cited by 51
“Cryopreserved primary human hepatocytes purchased from BioIVT were seeded on collagen-micropatterned 96-well plates, as described previously (29, 32).”
Self-citationDesign and Fabrication of a Liver-on-a-chip Reconstructing Tissue-tissue Interfaces
Liu, J., Feng, C., Zhang, M., Song, F., & Liu, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.959299 · Cited by 51
“Drug-induced hepatotoxicity or drug-induced liver injury (DILI) is the primary reason for discontinuing clinical trials and for drug withdrawal from the market, thus highlighting a pressing need for developing in vitro liver tissue models for drug screening and evaluation (8).”
BackgroundMicrofluidic experimental platform for producing size-controlled three-dimensional spheroids
Ota, H., & Miki, N. (2011) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2011.03.051 · Cited by 50
Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions
Bale, S. S., Moore, L., Yarmush, M., & Jindal, R. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0031 · Cited by 46
Three-dimensional in vitro gut model on a villi-shaped collagen scaffold
Yi, B., Shim, K. Y., Ha, S. K., Han, J., Hoang, H.-H., Choi, I., Park, S., & Sung, J. H. (2017) · BioChip Journal · doi:10.1007/s13206-017-1307-8 · Cited by 50
Liguori, G. R., Jeronimus, B. F., Liguori, T. T. A., Moreira, L. F. P., & Harmsen, M. C. (2017) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2017.0189 · Cited by 50
Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro
Hurrell, T., Ellero, A. A., Masso, Z. F., & Cromarty, D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.02.013 · Cited by 52
Fabrication and characterization of microfluidic liver-on-a-chip using microsomal enzymes
Lee, J., Kim, S. H., Kim, Y., Choi, I., & Sung, J. H. (2013) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2013.02.015 · Cited by 49
Caralt, M., Velasco, E., Lanas, A., & Baptista, P. M. (2014) · Organogenesis · doi:10.4161/org.29892 · Cited by 42
“Primary hepatocytes are known to require between 7 to 10 d in culture before their metabolic activity and gene transcription levels stabilize.(78) During this period of time, mature hepatocytes seeded into the scaffold showed metabolic activity with urea and albumin production(2,3) and ammonia clearance,(2,63) drug me…”
BackgroundJiang, L.-Y., Lv, B., & Luo, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.003 · Cited by 49
Mabry, K. M., Schroeder, M. E., Payne, S. Z., & Anseth, K. S. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b11359 · Cited by 49
Mandenius, C., Andersson, T. B., Alves, P. M., Batzl‐Hartmann, C., Björquist, P., Carrondo, M. J. T., Chesné, C., Coecke, S., Edsbagge, J., Fredriksson, J. M., et al. (2011) · Alternatives to Laboratory Animals · doi:10.1177/026119291103900210 · Cited by 49
Fraser, K., Bruckner, D. M., & Dordick, J. S. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00054 · Cited by 50
Yamamoto, J., Udono, M., Miura, S., Sekiya, S., & Suzuki, A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.010 · Cited by 46
Nazari, M., Chuang, P. A., Esfahani, J. A., & Rashidi, S. (2019) · International Journal of Heat and Mass Transfer · doi:10.1016/j.ijheatmasstransfer.2019.118892 · Cited by 49
Microfluidic based human-on-a-chip: A revolutionary technology in scientific research
Syama, S., & Mohanan, P. V. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.02.049 · Cited by 49
Choi, J., Lee, H., Jin, H. K., Bae, J., & Kim, G. M. (2012) · Lab on a Chip · doi:10.1039/c2lc40764g · Cited by 48
The application of engineered liver tissues for novel drug discovery
Lin, C., Ballinger, K. R., & Khetani, S. R. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1032241 · Cited by 44
“Thus, engineering tools such as micropatterning and microfluidics that allow for controlled spatial patterning of cells and perfusion have been used to extend the lifetime of PHHs in vitro by several weeks, thereby allowing better modeling of liver diseases and drug outcomes [14,20].”
BackgroundMethodInfluentialSelf-citationBsoul, A., Pan, S., Cretu, E., Stoeber, B., & Walus, K. (2016) · Lab on a Chip · doi:10.1039/c6lc00636a · Cited by 48
Bioengineering Methods for Analysis of Cells In Vitro
Underhill, G. H., Galie, P. A., Chen, C. S., & Bhatia, S. N. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155709 · Cited by 48
“By promoting the long-term in vitro stabilization of hepatocytes, particularly human hepatocytes, such an approach has enabled studies investigating drug metabolism, hepatocellular toxicity, and hepatotropic pathogens (Khetani & Bhatia 2008, Ploss et al. 2010).”
BackgroundMethodSelf-citationHariparsad, N., Ramsden, D., Palamanda, J. R., DeKeyser, J. G., Fahmi, O. A., Kenny, J. R., Einolf, H. J., Mohutsky, M. A., Pardon, M., Siu, Y. A., et al. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074567 · Cited by 47
Conceptual Design of Micro-Bioreactors and Organ-on-Chips for Studies of Cell Cultures
Mandenius, C. (2018) · Bioengineering · doi:10.3390/bioengineering5030056 · Cited by 47
Recent Advances in Microfluidic-Based Microphysiological Systems
Kang, S. (2021) · BioChip Journal · doi:10.1007/s13206-021-00043-y · Cited by 47
“Furthermore, this design has been extended to various different co-culture models, such as blood vessels [78, 79], airways [80], muscles [81], bones [82], liver [83, 84], kidney [85, 86], gut [87], and brain [88].”
Dynamic wetting in microfluidic droplet formation
Bashir, S., Solvas, X. C. I., Bashir, M., Rees, J. M., & Zimmerman, W. B. (2014) · BioChip Journal · doi:10.1007/s13206-014-8207-y · Cited by 46
Lee, S. H., & Jun, B. (2018) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2018.11.041 · Cited by 46
Analysis of cellular biomolecules and behaviors using microfluidic chip and fluorescence method
Li, N., Zhang, W., Li, Y., & Lin, J. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.05.029 · Cited by 46
Qin, J., Chang, M., Wang, S., Liu, Z., Zhu, W. Z., Wang, Y., Yan, F., Li, J., Zhang, B., Dou, G., et al. (2016) · Scientific Reports · doi:10.1038/srep37388 · Cited by 46
Compound Absorption in Polymer Devices Impairs the Translatability of Preclinical Safety Assessments
Kemas, A. M., Shafagh, R. Z., Taebnia, N., Michel, M., Preiss, L. C., Hofmann, U., & Lauschke, V. M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202303561 · Cited by 45
Banaudha, K. K., Orenstein, J. M., Korolnek, T., Laurent, G. C. S., Wakita, T., & Kumar, A. (2010) · Hepatology · doi:10.1002/hep.23616 · Cited by 45
“contribution of nonparenchymal cells that stabilize liver-specific functions and hepatic differentiation.(11,12)”
BackgroundNo, D. Y., Jeong, G. S., & Lee, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.009 · Cited by 45
Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening
Takayama, K., & Mizuguchi, H. (2016) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2016.10.408 · Cited by 45
Guo, R., Tang, W., Yuan, Q., Hui, L., Wang, X., & Xie, X. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.013 · Cited by 43
“It has been reported that oxygenated or microfabricated co-cultures could stabilize metabolic functions of primary hepatocytes for a fewweeks (Khetani and Bhatia, 2008; Kidambi et al., 2009), but not the proliferative capacity of the cells.”
BackgroundYajima, Y., Lee, C. N., Yamada, M., Utoh, R., & Seki, M. (2018) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2018.01.022 · Cited by 45
Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype.
Mukherjee, S., Zhelnin, L., Sanfiz, A., Pan, J., Li, Z., Yarde, M., McCarty, J., & Járai, G. (2019) · Europe PMC (PubMed Central) · Cited by 45
Sakolish, C., Reese, C. E., Luo, Y., Valdiviezo, A., Schurdak, M. E., Gough, A., Taylor, D. L., Chiu, W. A., Vernetti, L. A., & Rusyn, I. (2020) · Toxicology · doi:10.1016/j.tox.2020.152651 · Cited by 45
“2020), or to those in other liver MPS such as a micro-patterned coculture of hepatocytes and fibroblasts (Kang et al. 2020; Khetani and Bhatia 2008).”
BackgroundMeissner, R., Eker, B., Kasi, H., Bertsch, A., & Renaud, P. (2011) · Lab on a Chip · doi:10.1039/c1lc20212j · Cited by 46
Recent advances in liver‐on‐chips: Design, fabrication, and applications
Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 44
Kim, Y., Lasher, C. D., Milford, L. M., Murali, T. M., & Rajagopalan, P. (2010) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0012 · Cited by 37
“9,10 We hypothesized that the enhanced in vivo liver-like phenotypes in CS cultures were a result of the underlying differences in the transcriptional program between hepatocytes cultured in CS and HMs.”
Eggenschwiler, R., Loya, K., Wu, G., Sharma, A. D., Sgodda, M., Zychlinski, D., Herr, C., Steinemann, D., Teckman, J. H., Bals, R., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0017 · Cited by 44
Chen, Q., He, Z., Liu, W., Lin, X., Wu, J., Li, H., & Lin, J. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500383 · Cited by 44
Tetsuka, K., Ohbuchi, M., & Tabata, K. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.05.010 · Cited by 44
Kamei, K., Yoshioka, M., Terada, S., Tokunaga, Y., & Chen, Y. (2019) · Biomedical Microdevices · doi:10.1007/s10544-019-0423-8 · Cited by 44
“…of organs, such as the brain (Park et al. 2015), lung (Huh et al. 2010), heart (Zhang et al. 2016), gut (Kim et al. 2012), intestine (Trietsch et al. 2017), liver (Beckwitt et al. 2018; Gröger et al. 2018; Khetani and Bhatia 2008) or multiple tissues (Edington et al. 2018; Kamei et al. 2017).”
BackgroundKopec, A. K., Yokokawa, R., Khan, N., Horii, I., Finley, J. E., Bono, C. P., Donovan, C., Roy, J., Harney, J., Burdick, A. D., et al. (2021) · The Journal of Toxicological Sciences · doi:10.2131/jts.46.99 · Cited by 39
“As an example, albumin secretion, urea synthesis and cytochrome P450 expression were enhanced by coculturing primary human hepatocytes with stromal cells ( Khetani and Bhatia, 2008 ) or with endothelial cells ( Liu et al., 2014 ).”
Liang, S., Gan, C., Dai, Y., Zhang, C., Bai, X., Zhang, S., Wheeler, A. R., Chen, H., & Feng, L. P. (2021) · Lab on a Chip · doi:10.1039/d1lc00610j · Cited by 44
Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium
Rusyn, I., Sakolish, C., Kato, Y., Stephan, C., Vergara, L., Hewitt, P., Bhaskaran, V., Davis, M., Hardwick, R. N., Ferguson, S. S., et al. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac061 · Cited by 43
Engineering a stem cell house into a home
Gilbert, P. M., & Blau, H. M. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt44 · Cited by 43
Pewkliang, Y., Rungin, S., Lerdpanyangam, K., Duangmanee, A., Kanjanasirirat, P., Suthivanich, P., Sa‐ngiamsuntorn, K., Borwornpinyo, S., Sattabongkot, J., Patrapuvich, R., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2198-4 · Cited by 43
Parks, L. G., Beyer, B. K., Breslin, W., Brown, T. R., Chapin, R. E., Campion, S., Enright, B., Faustman, E., Foster, P. M. D., Hartung, T., et al. (2013) · ALTEX · doi:10.14573/altex.2013.3.353 · Cited by 43
“Examples of liver tissue engineering to map critical 3-D features into 2-D multi-well-based drug screening platforms (Du et al., 2006; Khetani and Bhatia, 2008; Toh et al., 2011) are readily applicable to the development of testicular toxicity testing applications.”
BackgroundMicrofluidic Liver-on-a-Chip for Preclinical Drug Discovery
Fu, J., Qiu, H., & Tan, C. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041300 · Cited by 42
“(A) reproduced with permission of [11], Copyright © 2008.”
BackgroundMethodUmehara, K., Cantrill, C., Wittwer, M., Lenarda, E. D., Klammers, F., Ekiciler, A., Parrott, N. J., Fowler, S. M., & Ullah, M. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000133 · Cited by 42
“HepatoPac is an example of a long-term human hepatocyte coculture system that maintains viability and functional expression of drug metabolizing enzymes for up to 7 days and is now well established (Khetani and Bhatia, 2008; Lin and Khetani, 2016), whereas other assay approaches, such as the Hurel microliver platform…”
BackgroundMethodMicrofluidic droplet-based functional materials for cell manipulation
Zheng, Y., Wu, Z., Lin, L., Zheng, X. S., Hou, Y., & Lin, J. (2021) · Lab on a Chip · doi:10.1039/d1lc00618e · Cited by 42
Chan, T. S., Yu, H., Moore, A., Khetani, S. R., & Tweedie, D. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053397fullarticlecorrection · Cited by 40
“, albumin secretion, urea synthesis, and drug metabolizing activities) (Khetani and Bhatia, 2008;Wang et al., 2010).”
BackgroundSelf-citationLithography-based 3D printed hydrogels: From bioresin designing to biomedical application
Ghazali, H. S., Askari, E., Ghazali, Z. S., Naghib, S. M., & Braschler, T. M. (2022) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2022.100667 · Cited by 42
Pharmaceutical Knowledge Governance: A Human Rights Perspective
Lemmens, T. (2013) · The Journal of Law Medicine & Ethics · doi:10.1111/jlme.12012 · Cited by 42
Ankam, S., Teo, B. K. K., Kukumberg, M., & Yim, E. K. F. (2013) · Organogenesis · doi:10.4161/org.25425 · Cited by 41
Monitoring and control of microbioreactors: An expert opinion on development needs
Gernaey, K. V., Baganz, F., Franco‐Lara, E., Kensy, F., Krühne, U., Lübberstedt, M., Marx, U., Palmqvist, E. A., Schmid, A., Schubert, F., et al. (2012) · Biotechnology Journal · doi:10.1002/biot.201200157 · Cited by 41
Hang, T.-C., Lauffenburger, D. A., Griffith, L. G., & Stolz, D. B. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00288.2011 · Cited by 38
Current therapies and future possibilities for drug development against liver-stage malaria
Raphemot, R., Posfai, D., & Derbyshire, E. R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82981 · Cited by 41
“With this technology, a “microscale of human liver cells” has been developed that takes into account higher-order processes absent in cell lines, such as interactions with neighboring cell types, extracellular matrices, and physical forces (87).”
MethodMagnetically controllable 3D microtissues based on magnetic microcryogels
Liu, W., Li, Y., Feng, S., Ning, J., Wang, J., Gou, M., Chen, H., Xu, F., & Du, Y. (2014) · Lab Chip · doi:10.1039/c4lc00081a · Cited by 40
Takahashi, H., Shimizu, T., Nakayama, M., Yamato, M., & Okano, T. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400297 · Cited by 40
Sistare, F. D., Mattes, W. B., & LeCluyse, E. L. (2016) · ILAR Journal · doi:10.1093/ilar/ilw025 · Cited by 40
Da-silva, F., Boulenc, X., Vermet, H., Compigne, P., Gerbal‐Chaloin, S., Daujat‐Chavanieu, M., Klieber, S., & Poulin, P. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.03.001 · Cited by 40
Primary hepatocytes and their cultures for the testing of drug-induced liver injury
Vilas‐Boas, V., Cooreman, A., Gijbels, E., Campenhout, R. V., Arnesdotter, E., Ballet, S., Annaert, P., Cogliati, B., & Vinken, M. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.08.001 · Cited by 40
Emerging liver organoid platforms and technologies
Lam, D. T. U. H., Dan, Y. Y., Chan, Y.-S., & Ng, H.-H. (2021) · Cell Regeneration · doi:10.1186/s13619-021-00089-1 · Cited by 32
Saxton, S. H., & Stevens, K. R. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.022 · Cited by 40
Otsuka, H., Sasaki, K., Okimura, S., Nagamura, M., & Nakasone, Y. (2013) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/14/6/065003 · Cited by 40
Green, C., Pramfalk, C., Morten, K., & Hodson, L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00192.2014 · Cited by 40
Wang, Y., Takeishi, K., Li, Z., Cervantes‐Alvarez, E., de l’Hortet, A. C., Guzman‐Lepe, J., Cui, X., & Zhu, J. (2017) · Organogenesis · doi:10.1080/15476278.2017.1322243 · Cited by 40
Microengineered Organ-on-a-chip Platforms towards Personalized Medicine
Kankala, R. K., Wang, S., & Chen, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190222143542 · Cited by 41
Metadata
- Authors
- Khetani, S. R., & Bhatia, S. N.
- Affiliations
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Bhatia, Sangeeta N
- Venue
- Nature Biotechnology
- Published
- 2007-11-18
- Volume
- 26
- Issue
- 1
- Pages
- 120-126
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2023296392
- Cited by
- 1,219
- References
- 41
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 36 · 2023: 49 · 2022: 64 · 2021: 56 · 2020: 68 · 2019: 73 · 2018: 81 · 2017: 86 · 2016: 93 · 2015: 77 · 2014: 76 · 2013: 90 · 2012: 75
- FWCI
- 38.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- human liver cells, liver-on-a-chip, hepatotoxicity, drug development, phase I and II metabolism, canalicular transport, hepatocyte secretion, gene expression profiling, tissue engineering, microtechnology
- MeSH terms
- Biological Assay, Cells, Cultured, Equipment Design, Humans, Miniaturization, Drug Design, Flow Injection Analysis, Cell Culture Techniques, Equipment Failure Analysis, Hepatocytes, Microfluidic Analytical Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.